Fisher & Paykel Healthcare Corporation Limited
FSPKF
$20.56
-$1.00-4.64%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.26B | 1.23B | 1.20B | 1.18B | 1.15B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.26B | 1.23B | 1.20B | 1.18B | 1.15B |
| Cost of Revenue | 463.30M | 454.75M | 444.94M | 451.55M | 452.11M |
| Gross Profit | 801.65M | 778.42M | 753.13M | 730.48M | 697.66M |
| SG&A Expenses | 327.91M | 322.93M | 317.06M | 317.78M | 314.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 926.50M | 912.83M | 896.61M | 901.80M | 894.98M |
| Operating Income | 338.45M | 320.34M | 301.46M | 280.22M | 254.79M |
| Income Before Tax | 340.22M | 319.21M | 297.47M | 242.33M | 183.38M |
| Income Tax Expenses | 84.20M | 79.48M | 74.57M | 75.26M | 74.82M |
| Earnings from Continuing Operations | 256.02 | 239.73 | 222.90 | 167.07 | 108.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 256.02M | 239.73M | 222.90M | 167.07M | 108.57M |
| EBIT | 338.45M | 320.34M | 301.46M | 280.22M | 254.79M |
| EBITDA | 408.31M | 388.90M | 368.52M | 345.55M | 317.57M |
| EPS Basic | 0.44 | 0.41 | 0.38 | 0.29 | 0.19 |
| Normalized Basic EPS | 0.36 | 0.34 | 0.32 | 0.29 | 0.26 |
| EPS Diluted | 0.43 | 0.41 | 0.38 | 0.28 | 0.18 |
| Normalized Diluted EPS | 0.36 | 0.34 | 0.31 | 0.29 | 0.26 |
| Average Basic Shares Outstanding | 2.35B | 2.34B | 2.34B | 2.34B | 2.34B |
| Average Diluted Shares Outstanding | 2.36B | 2.36B | 2.36B | 2.36B | 2.35B |
| Dividend Per Share | 0.25 | 0.25 | 0.25 | 0.26 | 0.26 |
| Payout Ratio | 48.58% | 46.75% | 44.64% | 52.76% | 69.51% |